02-15-2019, 03:17 AM
(This post was last modified: 02-15-2019, 03:18 AM by thepianist.)
When I was working in oncology, it became a big deal with CAR-T therapy bc 1 single treatment cost literally 750k. Ppl can’t afford that and some sides, including the dreaded ‘cytokine storm’ could easily claim a patient’s life.
For some it works, others...nothing. Some...death.
Long story short, if you were administered the drug and physicians see no improvement, or worsening of the malignancy, healthcare doesn’t pay them.
If the patients cancer goes into remission, the treatment is considered ‘successful’ and insurance coughs up the money.
Unfortunately ‘successful remission’ to oncologists varies doc to doc, institute to institute...and sadly...most companies consider success if the patient gains an extra 3-5 months.
For some it works, others...nothing. Some...death.
Long story short, if you were administered the drug and physicians see no improvement, or worsening of the malignancy, healthcare doesn’t pay them.
If the patients cancer goes into remission, the treatment is considered ‘successful’ and insurance coughs up the money.
Unfortunately ‘successful remission’ to oncologists varies doc to doc, institute to institute...and sadly...most companies consider success if the patient gains an extra 3-5 months.

